key: cord-0707442-20e9tuul
authors: Sun, Chenyu; Lowe, Scott; Zhou, Qin; Nanola Uy, John Patrick
title: Mutual recognition of COVID-19 vaccine to restore normal social activities and redistribute vaccines for the next stage of the pandemic
date: 2022-02-17
journal: Public Health
DOI: 10.1016/j.puhe.2022.02.003
sha: 00d3d23b57c47a5695a542de741a4fd6a1d4512d
doc_id: 707442
cord_uid: 20e9tuul

nan

To the editor,

were reported worldwide and more than 8 billion vaccine doses administered to the population. 1 Although an increasing trend of vaccination is observed, with the recovery of economy and various international travel restrictions, a new challenge emerged and affect the daily lives of many who intend to travel abroad. In addition, due to lack of enough international cooperation and research transparency in investigating the mixture of vaccines from different countries, healthcare agencies in some parts of the world may require the travelers to obtain certain series of vaccines and testing upon entrance. 2, 6, 7 The controversy is that, however, some travelers are unable to comply with these requirements or acquire the listed vaccine series as they are denied access per home country policies.

In conclusion, to accelerate the recovery of the economy and to restore international travel, researchers and international cooperations are urgently needed to investigate the mixture of different vaccines. It is also crucial for healthcare agencies and authorities to collaborate closely for mutual approval of COVID-19 vaccines manufactured in different countries.

COVID-19) dashboard. World Health Organization (WHO) website

COVID-19 vaccines WHO EUL issued

Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States

The fight to manufacture COVID vaccines in lower-income countries

Vax the world

Non-U.S. immigrants: Travel to the United States